Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Regulatory News

Date Source Headline
7th Mar 2017 2:30 pm RNS Annual Financial Report
6th Mar 2017 7:00 am RNS Directorate Change
3rd Mar 2017 7:00 am RNS ALLIANCE WITH SANOFI PASTEUR FOR MEDI8897
1st Mar 2017 4:30 pm RNS Total Voting Rights
28th Feb 2017 7:02 am RNS FDA approves once-daily Qtern for type-2 diabetes
24th Feb 2017 12:32 pm RNS CHMP positive opinion for ZS-9 in hyperkalaemia
20th Feb 2017 7:00 am RNS AZ licenses Zoladex to TerSera for the US & Canada
17th Feb 2017 7:00 am RNS Lynparza positive in metastatic BRCA breast cancer
16th Feb 2017 12:01 pm RNS SILIQ (BRODALUMAB) APPROVED BY US FDA
2nd Feb 2017 7:00 am RNS AZN: FY16 and Q4 2016 Results
1st Feb 2017 4:00 pm RNS Total Voting Rights
26th Jan 2017 10:00 am RNS SYMBICORT GRANTED PAEDIATRIC EXCLUSIVITY IN THE US
17th Jan 2017 7:00 am RNS AZ 1st-line lung cancer immuno-oncology programme
3rd Jan 2017 4:00 pm RNS Total Voting Rights
23rd Dec 2016 7:00 am RNS AZ COMPLETES SALE OF ANTIBIOTICS BUSINESS
16th Dec 2016 1:00 pm RNS Director/PDMR Shareholding
9th Dec 2016 3:05 pm RNS FDA accepts durvalumab for BLA in bladder cancer
6th Dec 2016 9:30 am RNS Tagrisso data shows superiority over chemotherapy
5th Dec 2016 7:00 am RNS AZ completes agreement for Rhinocort Aqua rights
1st Dec 2016 4:00 pm RNS Block listing Interim Review
1st Dec 2016 3:00 pm RNS Total Voting Rights
22nd Nov 2016 7:00 am RNS AZ head and neck cancer trials resume enrolment
17th Nov 2016 7:00 am RNS AZ out-licensing deal with Allergan completed
10th Nov 2016 7:04 am RNS Year-To-Date and Q3 2016 Results
9th Nov 2016 7:00 am RNS Directorate Change
1st Nov 2016 3:30 pm RNS Dealing by Person Closely Associated
1st Nov 2016 3:00 pm RNS Total Voting Rights
31st Oct 2016 1:47 pm RNS AZ completes US Aralez agreement for Toprol-XL
27th Oct 2016 4:51 pm RNS AstraZeneca Head and Neck Cancer Trials
26th Oct 2016 7:00 am RNS Positive results in AstraZeneca Lynparza trial
18th Oct 2016 7:00 am RNS FDA accepts for review ZS-9 NDA for hyperkalaemia
7th Oct 2016 7:00 am RNS AZ DIVESTS RIGHTS TO RHINOCORT AQUA OUTSIDE US
4th Oct 2016 7:05 am RNS AZ agreement with Aralez for Toprol-XL in US
4th Oct 2016 7:00 am RNS AstraZeneca reports top-line EUCLID results in PAD
3rd Oct 2016 3:00 pm RNS Total Voting Rights
3rd Oct 2016 7:00 am RNS MedImmune out-licenses medicine to Allergan
28th Sep 2016 7:00 am RNS CHANGE TO ASTRAZENECA BOARD OF DIRECTORS
26th Sep 2016 4:00 pm RNS Director/PDMR Shareholding
22nd Sep 2016 11:00 am RNS Director Declaration
1st Sep 2016 2:30 pm RNS Total Voting Rights
FTSE 100 Latest
Value8,275.66
Change0.00